PALISADE BIO INC (PALI) Stock Income Statement
NASDAQ:PALI - Nasdaq - US6963894026 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 250.00K | 0.00 | 0.00 | 13.50K | |||
| Operating Expenses | 14.86M | 13.10M | 15.31M | 11.74M | 10.69M | |||
| Research and Development | 9.06M | 6.89M | 6.55M | 2.43M | 2.02M | |||
| Selling, General, and Administrative Expenses | 5.80M | 6.20M | 8.76M | 9.31M | 8.67M | |||
| Operating Income | -14.86M | -12.85M | -15.31M | -11.74M | -10.68M | |||
| Interest Income/Expense | -12.00K | -15.00K | 2.41M | 20.64M | 28.80K | |||
| Other Income/Expense | 433.00K | 785.00K | -952.00K | -4.99M | -5.62M | |||
| Non Recurring Items | 0.00 | -225.00K | -410.00K | -30.52M | N/A | |||
| Income Before Taxes | -14.44M | -12.30M | -14.26M | -26.62M | -16.27M | |||
| Net Income | -14.44M | -12.30M | -14.26M | -26.62M | -16.27M | |||
| EBITDA | -14.86M | -12.84M | -15.31M | -11.73M | -10.58M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -10.19 | -26.97 | -242.93 | -2.15K | -5.25K | |||
| Non GAAP EPS | -11.78 | -29.10 | -247.95 | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | -4920.00% | N/A | N/A | -120494.81% | |||
| Operating Profit Margin | N/A | -5138.00% | N/A | N/A | -79078.52% | |||
All data in USD